Tumor-derived serum exosomal microRNA as a novel biomarker for high-grade serous carcinoma

被引:0
|
作者
Broach, V. [1 ]
Mueller, J. J. [1 ]
Schlappe, B. [1 ]
Bogomolniy, F. [1 ]
Bisogna, M. [1 ]
Dao, F. [1 ]
Jelinic, P. [1 ]
Levine, D. A. [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
10.1016/j.ygyno.2015.01.028
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
26
引用
收藏
页码:13 / 13
页数:1
相关论文
共 50 条
  • [1] LINE-1, A NOVEL BIOMARKER FOR HIGH-GRADE SEROUS OVARIAN CARCINOMA
    Nguyen, T. H. M.
    Upton, K. R.
    Faulkner, G. J.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 219 - 219
  • [2] Advancing NSCLC Diagnosis: The Role of Tumor-Derived Serum Exosomal SNORD60 as a Novel Biomarker
    Li, Lin
    Wang, Kangyu
    Yuan, Ning
    Zhang, Qun
    Liang, Xinmei
    Zhang, Zhijun
    [J]. INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024,
  • [3] A novel multiple biomarker panel for the early detection of high-grade serous ovarian carcinoma
    Han, Chanhee
    Bellone, Stefania
    Siegel, Eric R.
    Altwerger, Gary
    Menderes, Gulden
    Bonazzoli, Elena
    Egawa-Takata, Tomomi
    Pettinella, Francesca
    Bianchi, Anna
    Riccio, Francesco
    Zammataro, Luca
    Yadav, Ghanshyam
    Marto, Jarrod A.
    Penet, Marie-France
    Levine, Douglas A.
    Drapkin, Ronny
    Patel, Abhijit
    Litkouhi, Babak
    Ratner, Elena
    Silasi, Dan-Arin
    Huang, Gloria S.
    Azodi, Masoud
    Schwartz, Peter E.
    Santin, Alessandro D.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 (03) : 585 - 591
  • [4] DIAGNOSTIC AND PROGNOSTIC IMPACT OF MICRORNA EXPRESSION IN SERUM OF HIGH-GRADE SEROUS OVARIAN CARCINOMA PATIENTS
    Bignotti, E.
    Todeschini, P.
    Ravaggi, A.
    Ferracin, M.
    Sartori, E.
    Odicino, F.
    Tognon, G.
    Negrini, M.
    D'Incalci, M.
    Marchini, S.
    Romualdi, C.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 76 - 76
  • [5] High-grade serous carcinoma of the ovary
    Westfall, Danielle
    Roma, Andres A.
    Silva, Elvio G.
    [J]. ANNALS OF DIAGNOSTIC PATHOLOGY, 2009, 13 (04) : 285 - 290
  • [6] The "Far Left" of the Morphologic Spectrum of Ovarian High-grade Serous Carcinoma: Case Report of a Purely Noninvasive High-grade Serous Carcinoma Mimicking an Ovarian Serous Borderline Tumor
    Katsakhyan, Levon
    Baraban, Ezra G.
    Dumoff, Kimberly L.
    Burger, Robert A.
    Parikh, Rupal
    Cooper, Kumarasen
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2021, 40 (02) : 175 - 179
  • [7] Ovarian high-grade serous carcinoma with a noninvasive growth pattern simulating a serous borderline tumor
    Imamura, Hiroko
    Ohishi, Yoshihiro
    Aman, Murasaki
    Shida, Kaai
    Shinozaki, Tomoko
    Yasutake, Nobuko
    Sonoda, Keno
    Kato, Kiyoko
    Oda, Yoshinao
    [J]. HUMAN PATHOLOGY, 2015, 46 (10) : 1455 - 1463
  • [8] Extracellular microRNA profiling for prognostic prediction in patients with high-grade serous ovarian carcinoma
    Yoshida, Kosuke
    Yokoi, Akira
    Matsuzaki, Juntaro
    Kato, Tomoyasu
    Ochiya, Takahiro
    Kajiyama, Hiroaki
    Yamamoto, Yusuke
    [J]. CANCER SCIENCE, 2021, 112 (12) : 4977 - 4986
  • [9] High-Grade Serous Carcinoma of the Fallopian Tube
    Schoolmeester, J. Kenneth
    Erickson, Lori A.
    [J]. MAYO CLINIC PROCEEDINGS, 2020, 95 (10) : 2300 - 2301
  • [10] HMGA2: A biomarker significantly overexpressed in high-grade ovarian serous carcinoma
    Mahajan, Aparna
    Liu, Zhaojian
    Gellert, Lan
    Zou, Xuanyi
    Yang, Guangyu
    Lee, Peng
    Yang, Ximing
    Wei, Jian-Jun
    [J]. MODERN PATHOLOGY, 2010, 23 (05) : 673 - 681